TW202423421A - 預防或改善衰弱用之組成物,及抑制或改善高齡所伴隨之身體活動力降低用之組成物 - Google Patents

預防或改善衰弱用之組成物,及抑制或改善高齡所伴隨之身體活動力降低用之組成物 Download PDF

Info

Publication number
TW202423421A
TW202423421A TW112130758A TW112130758A TW202423421A TW 202423421 A TW202423421 A TW 202423421A TW 112130758 A TW112130758 A TW 112130758A TW 112130758 A TW112130758 A TW 112130758A TW 202423421 A TW202423421 A TW 202423421A
Authority
TW
Taiwan
Prior art keywords
composition
ergothioneine
frailty
present
salt
Prior art date
Application number
TW112130758A
Other languages
English (en)
Chinese (zh)
Inventor
勝部諒
鈴木寿栄
首藤剛
Original Assignee
日商三得利控股股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商三得利控股股份有限公司 filed Critical 日商三得利控股股份有限公司
Publication of TW202423421A publication Critical patent/TW202423421A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW112130758A 2022-08-17 2023-08-16 預防或改善衰弱用之組成物,及抑制或改善高齡所伴隨之身體活動力降低用之組成物 TW202423421A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022-130122 2022-08-17
JP2022130122 2022-08-17

Publications (1)

Publication Number Publication Date
TW202423421A true TW202423421A (zh) 2024-06-16

Family

ID=89941602

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112130758A TW202423421A (zh) 2022-08-17 2023-08-16 預防或改善衰弱用之組成物,及抑制或改善高齡所伴隨之身體活動力降低用之組成物

Country Status (4)

Country Link
JP (1) JPWO2024038821A1 (cg-RX-API-DMAC7.html)
CN (1) CN119604289A (cg-RX-API-DMAC7.html)
TW (1) TW202423421A (cg-RX-API-DMAC7.html)
WO (1) WO2024038821A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2024172003A1 (cg-RX-API-DMAC7.html) * 2023-02-16 2024-08-22
JPWO2025063190A1 (cg-RX-API-DMAC7.html) * 2023-09-19 2025-03-27

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7681882B2 (ja) * 2019-10-03 2025-05-23 学校法人沖縄科学技術大学院大学学園 フレイルの判定方法
JPWO2022230487A1 (cg-RX-API-DMAC7.html) * 2021-04-26 2022-11-03

Also Published As

Publication number Publication date
CN119604289A (zh) 2025-03-11
JPWO2024038821A1 (cg-RX-API-DMAC7.html) 2024-02-22
WO2024038821A1 (ja) 2024-02-22

Similar Documents

Publication Publication Date Title
CN115867289B (zh) 含有nr及/或nmn与芝麻素类的组合物
US20240180876A1 (en) Composition for increasing red blood cells and/or hemoglobin
CN117241796A (zh) 肾功能的降低抑制或改善用组合物
CN117255683A (zh) 免疫细胞的代谢促进用组合物
JP7796118B2 (ja) 白血球及び/又は好塩基球増加用組成物
WO2024038821A1 (ja) フレイル予防又は改善用組成物、及び、加齢に伴う身体活動能力低下を抑制又は改善するための組成物
JP2024069498A (ja) エルゴチオネイン又はその塩を含有する睡眠改善用組成物
TW202200129A (zh) 菸鹼醯胺腺嘌呤二核苷酸(nad)濃度上昇劑
US20240189284A1 (en) Composition for promoting lipolysis
US20250017905A1 (en) Composition for inhibiting histamine-n-methyltransferase
HK40124129A (en) Composition for ameliorating or preventing frailty, and composition for ameliorating or suppressing decline in physical activity capacity accompanying aging
KR20070095338A (ko) 간기능 개선제
TW202448445A (zh) 含有麥角硫因之肌肉萎縮抑制用組成物及Src酪胺酸激酶阻礙用組成物
TWI888414B (zh) 生活活動量之維持、預防降低、抑制降低或改善用組成物之使用
WO2024172002A1 (ja) エルゴチオネインを含有する血管拡張用組成物
HK40129889A (zh) 含有麦角硫因的血管扩张用组合物
CN121001582A (zh) 含有麦角硫因或其盐的用于预防、减轻或改善中暑或脱水症的组合物及用于调节细胞内外水分的组合物
TW202502321A (zh) 含有芝麻素類化合物及阿魏酸或其鹽之組成物
JP6436971B2 (ja) 朝鮮人参の実抽出物を含む、CD4及びCD8 memory cell減少用の組成物
HK40089668A (en) Composition containing sesamin or like and nr and/or nmn
HK40089161A (en) Nicotinamide adenine dinucleotide (nad) concentration increasing agent